|
HealthTrust Purchasing has entered a purchasing agreement with medical device and software company Zoll Medical for its intravascular temperature management system.
Zoll Medical, a manufacturer of resuscitation devices and software solutions, has reported fiscal 2009 revenues of $385.2 million, a decline of 3 percent compared to fiscal 2008 revenues of $398 million.
Zoll Medical, a manufacturer of resuscitation devices and related software solutions, has received FDA approval to market and sell an upgraded LifeVest wearable defibrillator.
Zoll Medical, a manufacturer of resuscitation devices and related software solutions, has entered into a multi-year agreement to license Inovise Medical's Audicor technology.
Zoll Medical, a manufacturer of resuscitation devices and software solutions, has reported net income of $1.78 million for the second quarter of 2009, compared with $5.65 million in net income for the same period last year.
Zoll Medical and FDA have notified healthcare professionals of a Class 1 recall of Zoll AED [automated external defibrillator] Plus Defibrillators distributed from May 2004 through Feb. 9, 2009. The recall was initiated because the device may fail to deliver a defibrillation shock, which could result in failure to resuscitate a patient during treatment of sudden cardiac arrest.
Zoll Medical, a manufacturer of resuscitation devices and software products, has filed a lawsuit in the Central District Court of California against Alsius and its subsidiary Alsius Medical, citing patent infringement over two temperature-management patents.
Zoll Medical, a manufacturer of resuscitation devices and related software products, has received 510(k) clearance from the FDA to market and sell its new Zoll R Series BLS and R Series Plus defibrillators.
Zoll Medical, a manufacturer of resuscitation devices and software solutions, has reported an increase in revenues and net income for its 2008 fiscal year.
|
Zoll Medical, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the FDA for a new model of the Zoll E Series Monitor/Defibrillator with carbon monoxide measurement.
Sandy Fire District, in Sandy, Oregon, an emergency service in the Portland area, has installed Zoll Medical's AutoPulse, an automated CPR device.
Basingstoke and North Hampshire Hospital in Hampshire, England, has installed Zoll Medical’s AutoPulse non-invasive cardiac support pump in the cardiac catheterization laboratory.
Zoll Medical has completed its acquisition of the assets of Alsius' intravascular temperature management device business for approximately $12 million.
Zoll Medical, a manufacturer of resuscitation devices and related software solutions, has received clearance from the State Food and Drug Administration (SFDA) of China to market and sell its R Series Code-Ready defibrillators to hospitals in the People's Republic of China.
Zoll Medical, through a wholly owned subsidiary, will purchase Alsius and all the assets constituting Alsius's intravascular temperature management device business, for approximately $12 million.
Zoll Medical, a manufacturer of resuscitation devices and software products, has reported its revenues for the 2009 first fiscal quarter were $89.5 million, compared to revenues in the first quarter of last year of $93 million, representing a decline of 4 percent.
Zoll Medical, a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the FDA to market and sell the Zoll R Series Code-Ready clinical defibrillator with a WiFi option that allows wireless communication between the defibrillator and standard hospital networks to help ensure code-readiness and download patient data.
Written by C.P. Kaiser
If Europe is any indication of where mechanical cardiopulmonary resuscitation (CPR) is heading, interventional cardiologists in the U.S. should get ready to welcome the devices into their cath labs. European researchers have begun to validate the technique in arrested patients undergoing PCI.
|
RSS 
Middle age introduces itself in many ways; one is atrial fibrillation (AF). My onset of AF seems to have coincided with a mountain bike accident in the woods of North Carolina that resulted in some cracked ribs.
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.
There are cases presented to all physicians when we have to balance benefits of a particular treatment with concerns around safety for certain patients. In interventional cardiology, we see this dilemma with drug-eluting stents (DES). While this technology provides effective therapy for many patients with ischemia-inducing coronary lesions, there are certain patient groups that encounter problems for different reasons.
U.S. News & World Report and HealthGrades surveys that rank “Best Hospitals” according to their high-quality cardiovascular care do not create the most comprehensive list and may create confusion by excluding hospitals that provide the same quality of care, according to a study published in the January issue of the Journal of the American College of Surgeons.